Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment
, , und
22. Juli 2021
Über diesen Artikel
Online veröffentlicht: 22. Juli 2021
Seitenbereich: 158 - 166
Eingereicht: 11. Juni 2020
Akzeptiert: 01. März 2021
DOI: https://doi.org/10.2478/prolas-2021-0025
Schlüsselwörter
© 2020 Ilona Hartmane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hartmane, Ilona
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Ivdra, Iveta
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Mikažāns, Ingmārs
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia
Department of Dermatology, Rīga Stradiņš UniversityLatvia
Bondare-Ansberga, Vanda
Clinical Centre of Skin and Sexually Transmitted DiseasesLatvia